TOP-LD: A tool to explore linkage disequilibrium with TOPMed whole-genome sequence data.
Journal
American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475
Informations de publication
Date de publication:
02 06 2022
02 06 2022
Historique:
received:
20
12
2021
accepted:
08
04
2022
pubmed:
4
5
2022
medline:
9
6
2022
entrez:
3
5
2022
Statut:
ppublish
Résumé
Current publicly available tools that allow rapid exploration of linkage disequilibrium (LD) between markers (e.g., HaploReg and LDlink) are based on whole-genome sequence (WGS) data from 2,504 individuals in the 1000 Genomes Project. Here, we present TOP-LD, an online tool to explore LD inferred with high-coverage (∼30×) WGS data from 15,578 individuals in the NHLBI Trans-Omics for Precision Medicine (TOPMed) program. TOP-LD provides a significant upgrade compared to current LD tools, as the TOPMed WGS data provide a more comprehensive representation of genetic variation than the 1000 Genomes data, particularly for rare variants and in the specific populations that we analyzed. For example, TOP-LD encompasses LD information for 150.3, 62.2, and 36.7 million variants for European, African, and East Asian ancestral samples, respectively, offering 2.6- to 9.1-fold increase in variant coverage compared to HaploReg 4.0 or LDlink. In addition, TOP-LD includes tens of thousands of structural variants (SVs). We demonstrate the value of TOP-LD in fine-mapping at the GGT1 locus associated with gamma glutamyltransferase in the African ancestry participants in UK Biobank. Beyond fine-mapping, TOP-LD can facilitate a wide range of applications that are based on summary statistics and estimates of LD. TOP-LD is freely available online.
Identifiants
pubmed: 35504290
pii: S0002-9297(22)00154-9
doi: 10.1016/j.ajhg.2022.04.006
pmc: PMC9247832
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1175-1181Subventions
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL129132
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL129982
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA052713
Pays : United States
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : U01 HG011720
Pays : United States
Organisme : NIAMS NIH HHS
ID : U24 AR076730
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146500
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002490
Pays : United States
Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests L.M.R. is a consultant for the TOPMed Administrative Coordinating Center (through Westat).
Références
Nat Commun. 2021 May 10;12(1):2579
pubmed: 33972514
Nucleic Acids Res. 2016 Jan 4;44(D1):D877-81
pubmed: 26657631
Am J Hum Genet. 2016 Jan 7;98(1):127-48
pubmed: 26748516
Nature. 2010 Sep 2;467(7311):52-8
pubmed: 20811451
Am J Hum Genet. 2021 Oct 7;108(10):1836-1851
pubmed: 34582791
Nat Genet. 2010 Apr;42(4):348-54
pubmed: 20208533
Am J Hum Genet. 2020 Jan 2;106(1):112-120
pubmed: 31883642
Nat Genet. 2016 Nov;48(11):1443-1448
pubmed: 27694958
J Hum Genet. 2022 Feb;67(2):87-93
pubmed: 34376796
Nature. 2021 Feb;590(7845):290-299
pubmed: 33568819
Am J Hum Genet. 2013 Aug 8;93(2):278-88
pubmed: 23910464
Bioinformatics. 2016 May 15;32(10):1493-501
pubmed: 26773131
Nat Rev Genet. 2008 Jun;9(6):477-85
pubmed: 18427557
Nature. 2020 Jul;583(7818):699-710
pubmed: 32728249
J Med Genet. 2016 Feb;53(2):111-2
pubmed: 26395054
Nature. 2020 Oct;586(7831):741-748
pubmed: 33116287
Nucleic Acids Res. 2017 Jan 4;45(D1):D896-D901
pubmed: 27899670
PLoS Comput Biol. 2012;8(12):e1002822
pubmed: 23300413
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Bioinformatics. 2018 Oct 15;34(20):3572-3574
pubmed: 29669011
Bioinformatics. 2015 Nov 1;31(21):3555-7
pubmed: 26139635